Recombinant human thrombopoietin does not promote platelet engraftment in newly diagnosed multiple myeloma patients following autologous stem cell transplantation

Recombinant human thrombopoietin does not promote platelet engraftment in newly diagnosed multiple myeloma patients following autologous stem cell transplantation

Abstract To evaluate the effect of recombinant human thrombopoietin (rhTPO) on platelet engraftment after autologous stem cell transplantation (ASCT) in newly diagnosed multiple myeloma (NDMM) patients. Clinical data of 40 NDMM patients who underwent high-dose melphalan conditioning and ASCT were an...

Full description

Saved in:
Bibliographic Details
Main Authors: Ruiqi Wang, Jing Cai, Ziqi Chen, Hao Tian, Dan Cong, Yuansong Bai, Wenlong Zhang
Format: Article
Language:English
Published: Nature Portfolio 2025-02-01
Series:Scientific Reports
Subjects:
Recombinant human thrombopoietin
Newly diagnosed multiple myeloma
Autologous hematopoietic stem cell transplantation
Hematopoietic reconstitution
Online Access:https://doi.org/10.1038/s41598-025-89535-7
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-025-89535-7

Similar Items